(Reuters) - Johnson & Johnson (NYSE:) has sued divisions of Cigna (NYSE:), accusing the health insurer of working with a drug-benefit middleman to drain J&J's financial-assistance funds earmarked for patients taking some of its pricier drugs, The Wall Street Journal reported on Friday.